Biohaven Ltd. (BHVN) insider trading

{
  "status": "OK",
  "results": [
    {
      "tickers": [
        "BHVN"
      ],
      "issuer_cik": "0001935979",
      "owner_cik": "0001027035",
      "accession_number": "0001027035-26-000006",
      "form_type": "4/A",
      "filing_date": "2026-03-09",
      "period_of_report": "2025-03-04",
      "issuer_name": "Biohaven Ltd.",
      "issuer_trading_symbol": "BHVN",
      "owner_name": "CHILDS JOHN W",
      "is_director": true,
      "is_officer": false,
      "is_ten_percent_owner": false,
      "is_other": false,
      "security_type": "non_derivative",
      "record_type": "transaction",
      "security_title": "Common Shares",
      "transaction_timeliness": "O",
      "aff_10b5_one": false,
      "transaction_date": "2025-03-04",
      "transaction_code": "P",
      "equity_swap_involved": false,
      "transaction_shares": 28400,
      "transaction_price_per_share": 30.4266,
      "transaction_acquired_disposed": "A",
      "shares_owned_following_transaction": 2323971,
      "transaction_value": 864115.4400000001,
      "date_of_original_submission": "2025-03-05",
      "not_subject_to_section_16": false,
      "direct_or_indirect": "I",
      "nature_of_ownership": "By John W Childs 2013 Revocable Trust",
      "footnotes": [
        {
          "id": "F1",
          "description": "This amendment is being filed to correct the nature of the indirect ownership reported in the Form 4 filed on March 5, 2025 (the \"Original Form 4\"). The Original Form 4 inadvertently misstated that 3,400 Common Shares were indirectly acquired by the Reporting Person through the 2013 Charitable Remainder Trust, and 25,000 Common Shares were indirectly acquired by the Reporting Person through the John W Childs 2013 Revocable Trust. However, as reflected in this amendment, 28,400 Common Shares were indirectly acquired by the Reporting Person through the John W Childs 2013 Revocable Trust, and no Common Shares were indirectly acquired by the Reporting Person through the 2013 Charitable Remainder Trust."
        },
        {
          "id": "F2",
          "description": "The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $30.17 - $30.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4."
        }
      ]
    },
    {
      "tickers": [
        "BHVN"
      ],
      "issuer_cik": "0001935979",
      "owner_cik": "0001878290",
      "accession_number": "0001878290-25-000004",
      "form_type": "4",
      "filing_date": "2025-11-18",
      "period_of_report": "2025-11-17",
      "issuer_name": "Biohaven Ltd.",
      "issuer_trading_symbol": "BHVN",
      "owner_name": "Clark George C.",
      "is_director": false,
      "is_officer": true,
      "is_ten_percent_owner": false,
      "is_other": false,
      "officer_title": "VP, Chief Accounting Officer",
      "security_type": "non_derivative",
      "record_type": "transaction",
      "security_title": "Common Shares",
      "transaction_timeliness": "O",
      "aff_10b5_one": false,
      "transaction_date": "2025-11-17",
      "transaction_code": "P",
      "equity_swap_involved": false,
      "transaction_shares": 17000,
      "transaction_price_per_share": 8.5159,
      "transaction_acquired_disposed": "A",
      "shares_owned_following_transaction": 20000,
      "transaction_value": 144770.30000000002,
      "not_subject_to_section_16": false,
      "direct_or_indirect": "I",
      "nature_of_ownership": "By IRA",
      "footnotes": [
        {
          "id": "F1",
          "description": "The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.4950 - $8.5200, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4."
        }
      ]
    }
  ]
}

// trimmed to 2 results

The response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.